Skip to main content
. 2021 Jan 6;16(1):e0244937. doi: 10.1371/journal.pone.0244937

Fig 4.

Fig 4

Assessment of pre-pandemic Dengue positive samples (PPS): A) Pre-pandemic samples (n = 84 samples) were tested using Abbott’s Architect SARS-CoV-2 IgG CMIA, 42 samples were from the acute phase and another 42 paired samples from the convalescent phase. The red dotted line represents the cutoff point for the CMIA (S/CO = 1.4); B) SARS-CoV-2 IgG immunoreactivity index (S/CO) displayed by acute samples and convalescent samples from Dengue positive patients. No significant differences were observed.